LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
87.71
+1.11 (1.28%)
At close: Feb 13, 2026, 4:00 PM EST
87.66
-0.05 (-0.05%)
After-hours: Feb 13, 2026, 4:00 PM EST
LeMaitre Vascular Revenue
LeMaitre Vascular had revenue of $61.05M in the quarter ending September 30, 2025, with 11.36% growth. This brings the company's revenue in the last twelve months to $240.87M, up 13.07% year-over-year. In the year 2024, LeMaitre Vascular had annual revenue of $219.86M with 13.63% growth.
Revenue (ttm)
$240.87M
Revenue Growth
+13.07%
P/S Ratio
8.12
Revenue / Employee
$362,750
Employees
664
Market Cap
1.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 219.86M | 26.38M | 13.63% |
| Dec 31, 2023 | 193.48M | 31.83M | 19.69% |
| Dec 31, 2022 | 161.65M | 7.23M | 4.68% |
| Dec 31, 2021 | 154.42M | 25.06M | 19.37% |
| Dec 31, 2020 | 129.37M | 12.13M | 10.35% |
| Dec 31, 2019 | 117.23M | 11.66M | 11.05% |
| Dec 31, 2018 | 105.57M | 4.70M | 4.66% |
| Dec 31, 2017 | 100.87M | 11.72M | 13.14% |
| Dec 31, 2016 | 89.15M | 10.80M | 13.78% |
| Dec 31, 2015 | 78.35M | 7.26M | 10.20% |
| Dec 31, 2014 | 71.10M | 6.55M | 10.14% |
| Dec 31, 2013 | 64.55M | 7.81M | 13.77% |
| Dec 31, 2012 | 56.74M | -950.00K | -1.65% |
| Dec 31, 2011 | 57.69M | 1.63M | 2.90% |
| Dec 31, 2010 | 56.06M | 5.15M | 10.12% |
| Dec 31, 2009 | 50.91M | 2.19M | 4.49% |
| Dec 31, 2008 | 48.72M | 7.27M | 17.55% |
| Dec 31, 2007 | 41.45M | 6.82M | 19.69% |
| Dec 31, 2006 | 34.63M | 3.90M | 12.70% |
| Dec 31, 2005 | 30.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.62B |
| ICU Medical | 2.32B |
| Stevanato Group | 1.37B |
| Warby Parker | 850.58M |
| Azenta | 595.03M |
| AtriCure | 518.31M |
| STAAR Surgical Company | 230.59M |
| BioLife Solutions | 100.14M |
LMAT News
- 2 days ago - LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026 - GlobeNewsWire
- 3 months ago - LeMaitre to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - LeMaitre Vascular, Inc. (LMAT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - LeMaitre Q3 2025 Financial Results - GlobeNewsWire
- 4 months ago - LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025 - GlobeNewsWire
- 5 months ago - LeMaitre Vascular: Investment Debate Remains In Place - Seeking Alpha
- 6 months ago - LeMaitre to Participate at Upcoming Investor Conferences in September - GlobeNewsWire
- 6 months ago - LeMaitre Vascular, Inc. (LMAT) Q2 2025 Earnings Call Transcript - Seeking Alpha